Evaluation of anti-cancer activity of PLGA nanoparticles containing crocetin

Artificial Cells, Nanomedicine and Biotechnology

Volumn 45, Issue 5, 2017, Pages 955-960

  Hafezi Ghahestani, Zohreh ^a   Alebooye Langroodi, Fatemeh ^a   Mokhtarzadeh, Ahad ^b,c   Ramezani, Mohammad ^d   Hashemi, Maryam ^e  

^a PAYAME NOOR UNIVERSITY   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HIGHER EDUCATION INSTITUTE OF RAB RASHID   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; crocetin; encapsulation; PLGA; saffron

Indexed keywords

CELL CULTURE; DICHLOROMETHANE; EMULSIFICATION; ENCAPSULATION; NANOPARTICLES;

CANCER; CHEMOTHERAPEUTIC AGENTS; CROCETIN; PLGA; POLY (VINYL ALCOHOL) (PVA); POLY(LACTIC-CO-GLYCOLIC ACID); PREPARATION CONDITIONS; SAFFRON;

DISEASES;

CROCETIN; DICHLOROMETHANE; NANOCARRIER; POLYGLACTIN; POLYVINYL ALCOHOL; ANTINEOPLASTIC AGENT; CAROTENOID; DRUG CARRIER; LACTIC ACID; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; CONTROLLED STUDY; CROCUS SATIVUS; CYTOTOXICITY; DOSE RESPONSE; DRUG RELEASE; EMULSION; EVAPORATION; FLOW CYTOMETRY; IC50; IN VITRO STUDY; MCF-7 CELL LINE; NANOENCAPSULATION; PARTICLE SIZE; ZETA POTENTIAL; APOPTOSIS; CHEMISTRY; DRUG EFFECTS; HUMAN;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CAROTENOIDS; DRUG CARRIERS; DRUG LIBERATION; HUMANS; LACTIC ACID; MCF-7 CELLS; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID;

EID: 84975267305     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.1080/21691401.2016.1198359     Document Type: Article

References (27)

1. Acharya S, Sahoo SK., 2011. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 63:170–183.
2. Alebooye Langroodi F, HG Z, Alibolandi M, Ebrahimian M, Hashemi M., 2016. Evaluation of the effect of crocetin on antitumor activity of doxorubicin encapsulated in PLGA nanoparticles. Nanomed J. 3:23–34.
3. Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, Aggarwal BB., 2010. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol. 79:330–338.
4. Bala I, Hariharan S, Kumar MR., 2004. PLGA nanoparticles in drug delivery:the state of the art. Crit Rev Ther Drug Carrier Syst. 21:387–422.
5. Bathaie S, Farajzade A, Hoshyar R., 2014. A review of the chemistry and uses of crocins and crocetin, the carotenoid natural dyes in saffron, with particular emphasis on applications as colorants including their use as biological stains. Biotech Histochem. 89:401–411.
6. Bhattacharyya SS, Paul S, De A, Das D, Samadder A, Boujedaini N, Khuda-Bukhsh AR., 2011. Poly (lactide-co-glycolide) acid nanoencapsulation of a synthetic coumarin:cytotoxicity and bio-distribution in mice, in cancer cell line and interaction with calf thymus DNA as target. Toxicol Appl Pharmacol. 253:270–281.
7. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V., 2012. PLGA-based nanoparticles:an overview of biomedical applications. J Control Release. 161:505–522.
8. Edel Sah, Hongkee Sah. 2015. Recent trends in preparation of poly(lactide-co-glycolide) nanoparticles by mixing polymeric organic solution with antisolvent. J Nanomater. 2015:2–22.
9. Giaccio M., 2004. Crocetin from saffron:an active component of an ancient spice. Crit Rev Food Sci Nutr. 44:155–172.
10. Gutheil WG, Reed G, Ray A, Anant S, Dhar A., 2012. Crocetin:an agent derived from saffron for prevention and therapy for cancer. Curr Pharm Biotechnol. 13:173–179.
11. Hashemi M, Parhiz H, Mokhtarzadeh A, Tabatabai SM, Farzad SA, Shirvan HR, Ramezani M., 2015. Preparation of effective and safe gene carriers by grafting alkyl chains to generation 5 polypropyleneimine. AAPS PharmSciTech. 16:1002–1012.
12. Kim D, El-Shall H, Dennis D, Morey T., 2005. Interaction of PLGA nanoparticles with human blood constituents. Colloids Surf B Biointerfaces. 40:83–91.
13. Lu JM, Wang X, Marin-Muller C, Wang H, Lin PH, Yao Q, Chen C., 2009. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn. 9:325–341.
14. Makadia HK, Siegel SJ., 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel). 3:1377–1397.
15. Moayedian TMF, Khameneh B, Tafaghodi M., 2015. Combined effects of PEGylation and particle size on uptake of PLGA particles by macrophage cells. Nanomed J. 2:299–304.
16. Mukerjee A, Vishwanatha JK., 2009. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 29:3867–3875.
17. Nair KL, Thulasidasan AKT, Deepa G, Anto RJ, Kumar GV., 2012. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier. Int J Pharm. 425:44–52.
18. Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE., 2014. Curcumin nanoformulations:a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 35:3365–3383.
19. Nam KN, Park Y-M, Jung H-J, Lee JY, Min BD, Park S-U, et al. 2010. Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. Eur J Pharmacol. 648:110–116.
20. Narayanan K, Subrahmanyam VM, Venkata Rao J., 2014. A fractional factorial design to study the effect of process variables on the preparation of hyaluronidase loaded PLGA nanoparticles. Enzyme Res. 2014:162962.
21. Ranjan AP, Mukerjee A, Helson L, Vishwanatha JK., 2012. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. J Nanobiotechnol. 10:38.
22. Sahoo SK, Panyam J, Prabha S, Labhasetwar V., 2002. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 82:105–114.
23. Schmidt M, Betti GandHensel A., 2007. Saffron in phytotherapy:pharmacology and clinical uses. Wien Med Wochenschr. 157:315–319.
24. Sharma N, Madan P, Lin S., 2016. Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles:a co-surfactant study. Asian J Pharm Sci. 11:404–416.
25. Tsai YM, Chien CF, Lin LC, Tsai TH., 2011. Curcumin and its nano-formulation:the kinetics of tissue distribution and blood–brain barrier penetration. Int J Pharm. 416:331–338.
26. Verderio P, Bonetti P, Colombo M, Pandolfi L, Prosperi D., 2013. Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells. Biomacromolecules. 14:672–682.
27. Wang H, Jia Y, Hu W, Jiang H, Zhang J, Zhang L., 2013. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin. Pharm Dev Technol. 18:694–700.